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CASE REPORT
INTRODUCTION
Inflammatory bowel disease (IBD) is an idiopathic
chronic inflammatory disease involving gastrointestinal
tract, with clinical symptoms of chronic diarrhea
accompanied with fever, abdominal pain, and weight
loss. It consists of ulcerative colitis (UC) and Crohn’s
disease (CD). Both diseases are common among
Caucasians (particularly Jewish), Africans, Americans
and Hispanics. However, it is very rare in
the Mongoloid race. IBD has peaks of onset at age
15-30 years and 60-80 years.1 Pathogenesis of IBD
may include a combination of environmental factors
(such as smoking, diet) and genetic along with the
normal intestinal flora or certain unidentified
microorganisms triggering intestinal response both of
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ABSTRACT
Ulcerative colitis (UC) is a form of inflammatory bowel disease (IBD) that usually affects the rectum
and part of the colon, which spreads continuously with no skip area. Pancolitis occurs in 20% of patients
with UC. Patients with chronic UC, especially pancolitis, have a higher risk of colon cancer. In patients
with pancolitis, the risk of cancer increases by 0.5-1% per year after having 8-10 years of disease.
A 72-year-old man came with complaint of bloody-mucus diarrhea associated with abdominal cramps.
The colonoscopic appearance of colitis was observed in whole lumen throughout colon. Histopathological
analysis demonstrated dense infiltrates of granulocytes and macrophages formed by severe inflammation.
Normal appearances were observed in the remaining epithelial cells. No parasites, specific process, or
malignancy were found. Moreover, no acid-resistant bacteria were found. However, atypical cells were
found in one of the biopsy specimens.
The patient was diagnosed with extensive type of severe UC. The initial management of treatment
included improvement of his general condition along with antibacterial therapy of metronidazole and
ciprofloxacin. Specific treatment of sulphasalazine and prednisone were given after pancolitis appearance
was revealed, which has similar clinical manifestations in accordance with UC.
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the immune cells (T cells, B cells, eosinophils,
neutrophils, monocytes) and non-immune cells
(endothelial, epithelial, mesenchymal, neural cells, and
matrix).1,2
Activated cellular immune response consequently
stimulates effectors T cells, macrophages, neutrophils
and other leukocytes. In addition, the humoral immune
response also stimulates B cells to produce
antibodies. Mediator secretion increases activation,
amplification and the production of antibodies and
autoantibodies, cytokines, growth factors, eicosanoid,
neuropeptides, reactive oxygen metabolites (ROMs),
nitric oxide (NO), and proteolytic enzymes. Thus,
inflammation and tissue damage occur in IBD.3 In CD,
transmural inflammation occurs, whereas in UC it is
limited to the mucosa. Genetic factors play a more
dominant role in CD when compared to IBD colitis
ulseratif.2 In IBD, there is a mutation in genes IL10RA
and IL10RB encoding IL10R1 and IL10R2 subunit
proteins, which form a heterotetramer to make up the
interleukin-10 receptor and consequently causes
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immune response of intestinal hyperinflammation.4
Acute exacerbation of IBD can occur because of
infection, consumption of non-steroidal anti-inflammatory
drugs (NSAIDs), and stress.1
Clinical manifestations that can be found in UC
include bloody-mucus diarrhea, fever, abdominal pain,
tenesmus and weight loss.5,6 All of these manifestations
depend on the severity of the disease spectrum. When
it is severe, dehydration, anemia, hypokalemia, and
hypoalbuminemia may occur.1,7 Through sigmoidoscopy/
colonoscopy, we can find mucosal redness, granular,
exudative and easily bleed mucosa as well as ulcers
and pseudopolyp in patients with UC. On biopsy,
epithelial damage, inflammation, crypt abscess, as well
as loss of goblet cells will be revealed.1
The management of UC includes providing supportive
treatment such as antidiarrhea, sulphasalazine,
glucocorticoids, or immunosuppressive agents, which
is administered to patients depending on the severity
and extent of illness.7 Further monitoring and
continuous follow up is necessary to prevent and
perform early detection on colorectal malignancy.8,9
UC usually involves the rectum and part of the colon
and spreads continuously (no skip areas). Pancolitis
only occurs in 20% of patients with UC.1 Stonnington,
et al demonstrated that of all UC cases, pancolitis only
occurs in one-third of all cases (4.6/100,000 cases/
year), while proctitis and other abnormalities in
the distal colon are more common, namely 7.1 and
2/100,000 cases/year in contrast to severe and
moderate UC cases which occurs only in 3.8/100,000
cases/year.10 In addition to IBD, pancolitis also caused
by Escherichia coli O157 : H7 that produces
verotoxin, Campylobacter jejuni, penicillin derivatives,
cephalosporins and quinolones, Salmonella, Yersinia,
Shigella, Entamoeba, and Cytomegalovirus.11,12,13
CASE ILLUSTRATION
A 72-year-old man came with complaint of
bloody-mucus diarrhea associated with abdominal
cramps since 2 months before admission. The stools
were yellow, mucus and mixed with a little amount of
fresh red blood. The patient had tenesmus. He also
had a history of intermittent diarrhea, slight fever,
nausea, loss of appetite, and 10 kg weight loss (more
than 10%) in the last 2 months period. In the past week,
diarrhea episodes increased (about 10 times per day).
Since 2 days before admission, he had less urine
output and concentrated yellow-dark colored urine.
He also felt dry mouth and throat as well as extreme
thirst. There was no history of foreign travel or
ingestion of unusual foods. No one had similar disease
in his family. The patient had a lack of fruit and
vegetables in the diet. There was no history of drugs
consumption (analgesics, herbal appetite stimulants,
drug addiction). There was no history of pulmonary
tuberculosis. The patient was a heavy smoker.
Physical examination revealed a patient with
moderate dehydration (compos mentis, dry mucous
membrane of mouth and tongue, dry skin, decreased
skin turgor). The patient was anemic but
hemodynamically stable with pulse rate of 80 beats
per minute, febrile (38°C) and tenderness on all four
abdominal quadrants (particularly the right lower
quadrant). No signs of acute abdomen or appendicitis
were observed. Pitting edema was found on the dorsal
surface of both feet. On digital rectal examination, no
anal fistula, fissures or abscess was found. There was
pain in anal canal and yellow liquid stool with a little
amount of fresh red blood was found.
The laboratory test showed anemia (hemoglobin
8.9 g/dL), leukocytosis (15,400/µL), and erythrocyte
sedimentation rate (ESR) 50 mm/hour, eosinophil 0,
basophil 0, segmented neutrophil 2 x 109/L, banded
neutrophil 83 x 109/L, lymphocyte 13 x 109/L, monocyte
2 x 109/L. Peripheral blood smear demonstrated
normocytic-normochromic anemia. The serum iron (SI)
level was 37 µg/dL and total iron binding capacity
(TIBC) was 188 µg/dL. Hyponatremia 131 mmol/L,
hypokalemia 2.4 mmol/L and hypoalbuminemia
1.9 g/dL were also found. His random blood glucose
level was 91 mg/dL and his quantitative C-reactive
protein (CRP) was 15.8 mg/L. On microscopic stool
analysis, mucus and blood were present in the stool,
leukocytes 3-4/high power field (HPF), erythrocytes
4-6/HPF. Parasitological stool examination
demonstrated negative result of parasites (no amoeba
was found neither in trophozoites or cysts form; eggs,
larva or adult worms were not found).
On chest X-ray, no appearance of pulmonary
tuberculosis was found. The 3-view-abdominal
radiograph revealed no appearance of ileus or
perforation. Abdominal ultrasonography showed no
abnormality. Colonoscopy revealed the appearance of
pancolitis (erosive, edematous and hyperemic mucosa
with multiple patchy exudative ulcer from rectum to
caecum, there was partial loss of haustra in
the descending colon, no mass was found).
Subsequently, 10 biopsies were taken from various
regions, i.e. from rectum to caecum. Histopathological
analysis demonstrated dense infiltrates of granulocytes
and macrophages formed by severe inflammation.
Normal appearances were observed in the remaining
epithelial cells. No parasites, specific process, or
malignancy were found. Moreover, no acid-resistant
bacteria were found. However, atypical cells were
found in one of the biopsy specimens.
Based on these findings, the diagnosis of extensive
type of severe UC was made. The management of
treatment included improvement of patient’s general
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pancolitis appearance was revealed, which has
similar clinical manifestations in accordance with UC.
DISCUSSION
Diarrhea is a loose, watery and frequent stool. It is
considered chronic when it had last for more than four
weeks. Generally, chronic diarrhea may arise by
non-infectious causes.6
In patients with chronic diarrhea, there are various
possible mechanisms of pathophysiology such as a
variety of pathophysiological mechanisms, including
secretoric, osmotic, steatorrheal, inflammatory,
dysmotile, and factitial mechanism.
Initial approach for patients with chronic diarrhea
includes history taking, physical examination and
laboratory work-up. When taking history, the onset,
duration, triggering and relieving factors as well as
stool characteristics should be asked. Further questions
should also be asked including the presence of fecal
incontinence, fever, weight loss, pain, history of specific
exposure (travel, medical treatment, contact with
diarrhea patients) and extra-intestinal manifestation
(skin changes, arthralgia, oral aphthous ulcer).
A question about family history of IBD or sprue should
also need to be asked.
On physical examination, we should examine
the presence of a thyroid gland, wheezing, murmurs,
edema, hepatomegaly, abdominal mass, lympha-
denopathy, mucocutaneous abnormalities, perianal
fistula or abnormalities of anal sphincter.6
Peripheral blood test should be performed to detect
leukocytosis, increased erythrocyte sedimentation rate
or CRP level indicating active inflammation.6,8 Anemia
suggests nutrient deficiencies or the presence of
bleeding; while eosinophilia suggests parasites,
neoplasia, connective tissue disease, allergies, or
eosinophilia gastroenteritis. Blood chemistry test may
reveal electrolyte status, liver function, or other
metabolic disorders.6
We present a case of a 72-year-old man who had
bloody-mucus diarrhea for two months. Other clinical
findings include fever, abdominal pain, tenesmus, and
weight loss. He also had dehydration, anemia of
chronic inflammation, hyponatremia, hypokalemia, and
hypoalbuminemia. Chronic diarrhea (over 4-weeks
period) accompanied with mucus and bleeding in such
patient may be caused by inflammatory mechanisms
(which may be due to infection, malignancy, and IBD).
We performed stool microscopic analysis to exclude
the possible infection. Based on such test, no amoeba
cyst and worm were found. By history taking,
physical examination and performing laboratory test
upon admission, we considered a working diagnosis of
IBD with differential diagnosis of colon cancer and
intestinal tuberculosis. In order to confirm the cause
of diarrhea, we subsequently proceed to colonoscopy
and biopsies.
Treatment provided at that time includes
improvement of general condition (fluid resuscitation,
correction of hyponatremia, hypokalemia, hypo-
albuminemia, and blood transfusion), symptomatic
therapy (antipyretic, antidiarrheal, antacids), and
antibacterial therapy (metronidazole and ciprofloxacin).
After the patient in stable condition, colonoscopy and
biopsies were performed. Based on physical and
laboratory findings, i.e. bloody-mucus diarrhea, absence
of abdominal mass, anal fistula, fissure and abscess,
negative signs of gastrointestinal tract obstruction, and
positive findings of continuous granulomatous
appearance (no skip areas, no rectal sparing) in
colonoscopy, we established a confirmed diagnosis of
severe UC with extensive type (pancolitis).
The disease was categorized as severe since there
was frequent defecation of more than six times a day,
fever, anemia with less than 75% of normal value,
erythrocyte sedimentation rate more than 30 mm/hour,
and the presence of ulceration and spontaneous
bleeding in the colon. It was classified as extensive
type because it involves part of colon which is more
proximal than the splenic flexure (or even classified
as pancolitis since the abnormalities were found in all
colon, from rectum to caecum).5,8 Metronidazole and
ciprofloxacin were discontinued and sulfasalazine and
prednisone were administered orally in accordance with
the management of active phase on the extensive type
of severe UC.7
UC usually involves the rectum and part of the colon
and spreads continuously (no skip areas). Pancolitis
only occurs in 20% of patients with UC.1 Based on
 
Figure 1. Colonoscopy showed UC with pancolitis
condition along with initial antibacterial therapy of
metronidazole and ciprofloxacin. Specific treatment of
sulphasalazine and prednisone were given after
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a study conducted by Stonnington, et al, pancolitis UC
only occurs in one-third of all cases (4.6/100,000 cases/
year), while proctitis and other abnormalities in
the distal colon are more common, namely 7.1 and
2/100,000 cases/year in contrast to severe and
moderate UC cases which occurs only in 3.8/100,000
cases/year.10
Histopathological analysis of biopsy specimens of
the patient showed atypical cells in 1 of 10 biopsy
specimens. However, it has not been considered
further whether these cells were included in
the low-grade dysplasia or high-grade dysplasia,
according to IBD dysplasia morphology-group
(DMG).5 In addition to both types of dysplasia,
there is indefinite type of dysplasia. Indefinite
dysplasia may offer findings of cells atypical cytoplasm
and nuclei (loss of polarity, larger and hyperchromatic
nuclei), but the cause of development of dysplasia is
unknown.
Cell damage both caused by inflammation
(reparative process) and neoplasia may result in
atypical cells. Colonoscopy and more frequent multiple
biopsies should be performed, in which cell damage
due to inflammatory processes (reparative process)
will gradually disappear over the course of therapy.
Moreover, biopsy results should be assessed by
the pathology anatomy gastroenterologist.9 When there
is evidence that those cells are high-grade dysplasia
or colorectal malignancy, surgical treatment such as
colectomy would be necessary. Surgical treatment may
also be considered for low-grade dysplasia, regarding
54% of low-grade dysplasia would become colorectal
cancer within five years.5
The risk of malignancy of the colon in chronic UC
increases with the duration and extent of disease.1
Chronic UC (> 10 years), particularly the pancolitis
type, has a higher risk of such cancer.14 In patients
with pancolitis, the risk of cancer increases by 0.5-1%
per year after having 8-10 years of disease.1
Based on colonoscopy and histopathological
results, the patient should have annual colonoscopy
or two times in a year with multiple biopsies as
a screening for dysplasia and colorectal carcinoma by
Colitis-Associated Colorectal Cancer (CAC).1,5
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